Psoriasis in children

Roxanne Pinson,1 Bahman Sotoodian,2 Loretta Fiorillo2,3 1School of Medicine, 2Division of Dermatology and Cutaneous Sciences, Department of Medicine, 3Division of Pediatric Dermatology, Department of Pediatrics, University of Alberta, Edmonton, AB, Canada Abstract: The clinical presentation, disease...

Full description

Saved in:
Bibliographic Details
Main Authors: Pinson R (Author), Sotoodian B (Author), Fiorillo L (Author)
Format: Book
Published: Dove Medical Press, 2016-10-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_620b04783c3a41a5a4a2f0e4bc21c91f
042 |a dc 
100 1 0 |a Pinson R  |e author 
700 1 0 |a Sotoodian B  |e author 
700 1 0 |a Fiorillo L  |e author 
245 0 0 |a Psoriasis in children 
260 |b Dove Medical Press,   |c 2016-10-01T00:00:00Z. 
500 |a 2230-326X 
520 |a Roxanne Pinson,1 Bahman Sotoodian,2 Loretta Fiorillo2,3 1School of Medicine, 2Division of Dermatology and Cutaneous Sciences, Department of Medicine, 3Division of Pediatric Dermatology, Department of Pediatrics, University of Alberta, Edmonton, AB, Canada Abstract: The clinical presentation, disease associations, and diverse treatment modalities in overcoming the challenges of managing pediatric psoriasis have been extensively summarized in this article. An extensive literature review revealed the differences in presentation of psoriasis during infancy, childhood, and adolescence. We also summarized the latest topical, systemic, and biological modalities in treating recalcitrant psoriasis. The association of psoriasis with juvenile arthritis and obesity and the significant influence of the disease on the children's quality of life were explored. The clinical presentation of psoriasis can evolve during the child's lifespan. While many treatment modalities already exist for treating pediatric psoriasis, some of the new biologics that are approved for adult patients have not been investigated in the pediatric population and no algorithm exists for their use in this population. Large clinical studies in the future will enhance our understanding with regards to their safety and potential implications in pediatric populations. Keywords: pediatric, epidemiology, juvenile arthritis, topical treatment, systemic treatment, phototherapy, biologics 
546 |a EN 
690 |a Psoriasis 
690 |a Pediatric 
690 |a Epidemiology 
690 |a Juvenile arthritis 
690 |a Topical treatment 
690 |a Systemic treatment 
690 |a Phototherapy 
690 |a Biologics 
690 |a Dermatology 
690 |a RL1-803 
655 7 |a article  |2 local 
786 0 |n Psoriasis: Targets and Therapy, Vol Volume 6, Pp 121-129 (2016) 
787 0 |n https://www.dovepress.com/psoriasis-in-children-peer-reviewed-article-PTT 
787 0 |n https://doaj.org/toc/2230-326X 
856 4 1 |u https://doaj.org/article/620b04783c3a41a5a4a2f0e4bc21c91f  |z Connect to this object online.